Cas 389844-67-1,1H-Pyrrolo[2,3-h]isoquinoline, 4-(4-chloro-3-fluorophenyl)-2,3,4,7-tetrahydro-2-methyl-

389844-67-1

Post Buying Request

Basic information

Product Name: 1H-Pyrrolo[2,3-h]isoquinoline, 4-(4-chloro-3-fluorophenyl)-2,3,4,7-tetrahydro-2-methyl-
Synonyms:
CAS NO:389844-67-1
Molecular Formula: C18H16ClFN2
Molecular Weight: 314.79
EINECS: N/A
Product Categories: N/A
Mol File: 389844-67-1.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1H-Pyrrolo[2,3-h]isoquinoline, 4-(4-chloro-3-fluorophenyl)-2,3,4,7-tetrahydro-2-methyl-(CAS DataBase Reference)
NIST Chemistry Reference: 1H-Pyrrolo[2,3-h]isoquinoline, 4-(4-chloro-3-fluorophenyl)-2,3,4,7-tetrahydro-2-methyl-(389844-67-1)
EPA Substance Registry System: 1H-Pyrrolo[2,3-h]isoquinoline, 4-(4-chloro-3-fluorophenyl)-2,3,4,7-tetrahydro-2-methyl-(389844-67-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 389844-67-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

389844-67-1 Suppliers

Recommended suppliers

389844-67-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 389844-67-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,9,8,4 and 4 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 389844-67:
(8*3)+(7*8)+(6*9)+(5*8)+(4*4)+(3*4)+(2*6)+(1*7)=221
221 % 10 = 1
So 389844-67-1 is a valid CAS Registry Number.

389844-67-1Upstream product

389845-73-2 C₁₈H₁₈ClFN₂O

389844-67-1Downstream Products

389844-68-2 C₁₉H₁₈ClFN₂

389844-67-1Relevant academic research and scientific papers

Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof

-

Page/Page column 24, (2010/11/08)

The present invention relates to a method of treating disorders including cognition impairment, generalized anxiety disorder, acute stress disorder, social phobia, simple phobias, pre-menstrual dysphoric disorder, social anxiety disorder, major depressive

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 389844-67-1